酒精使用障碍男性中与禁欲相关的因素:一种定性研究
Backiyaraj Shanmugam1, Jayant Mahadevan2, Dhanasekara Pandian Ramasamy1
1Dept. of Psychiatric Social Work, National Institute of Mental Health and Neuro-Sciences (NIMHANS), Bengaluru, Karnataka, India.
Indian journal of psychological medicine
|August 18, 2025
概括
患有酒精使用障碍 (AUD) 的男性持续戒酒是通过就业,治疗,社会支持和责任来促进的. 加强后护理服务和家庭干预对于降低复发风险至关重要.
科学领域:
- 成 药物 药物 药物 药物
- 心理学 心理学 心理学
- 社会学 社会学 社会学
背景情况:
- 酒精使用障碍 (AUD) 的恢复是复杂的,涉及复发和缓解.
- 持续的戒断是AUD的主要治疗目标.
- 这项研究侧重于在经常复发的男性中促进禁欲的因素.
研究的目的:
- 探索促进AUD男性禁欲的因素和频繁住院的因素.
- 确定在一个脆弱的患者群体中促进持续清醒的关键因素.
主要方法:
- 招募了29名患有AUD和频繁复发的男性.
- 数据通过六个焦点小组讨论 (FGD) 在四个月内收集.
- 使用ATLAS.ti软件对转录的FGD进行感应主题分析.
主要成果:
- 五个主题出现了:就业,治疗,恐惧,社会支持和责任.
- 有益因素包括退院后的支持,厌恶疗法,工作安全,家庭承诺和同行支持.
- 具体内容:电话跟踪,免费药物,治疗师的可用性,家庭认可,迪苏尔菲拉姆,害怕失去工作,儿童福利,不喝酒的朋友.
结论:
- 后期护理服务,工作场所支持和家庭干预是至关重要的.
- 将促进戒断的因素纳入治疗计划可以减少复发并改善结果.
相关概念视频
Substance Use Disorders Affecting Sleep
217
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
217
Antisocial Personality Disorder
174
Antisocial personality disorder is a chronic mental health condition characterized by persistent patterns of disregard for the rights and well-being of others. Individuals with antisocial personality disorder exhibit behaviors that include deceitfulness, impulsivity, irresponsibility, aggression, and a profound lack of empathy. These traits often manifest early in life and persist into adulthood, leading to significant personal, social, and legal consequences.
Behavioral Characteristics and...
Behavioral Characteristics and...
174
Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
Psychological and Sociocultural Causes of Schizophrenia
185
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
185
Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114
Factors Influencing Drug Absorption: Presystemic Elimination
340
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
340


